Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study optimizing and validating laser irradiation conditions for hematoporphyrin sodium photodynamic therapy in advanced esophageal cancer
CTR20200598Phase 2Active
- Sponsor
- Qinglong High-Tech
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cosiporfin sodium in esophageal cancer, sponsored by Qinglong High-Tech. Started Jul 2020; status: active.
02
Drugs
cosiporfin sodium
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on CTR20200598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200598.